Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland G Henry

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
JAMA Neurology|June 1, 2016
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple SclerosisNoriko Isobe, Anisha Keshavan, Pierre-Antoine Gourraud, et al.
Neurology|December 23, 2024
Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple SclerosisHannah E Silverman, Alan Bostrom, Alyssa N Nylander, et al.
Multiple Sclerosis and Related Disorders|April 9, 2022
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trialRiley Bove, Annika Anderson, William Rowles, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Nature Communications|May 20, 2024
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Brain : a Journal of Neurology|December 16, 2017
Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injuryBruce A C Cree, Jianqin Niu, Kimberly K Hoi, et al.
Brain : a Journal of Neurology|March 7, 2022
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in EuropeansHengameh Shams, Xiaorong Shao, Adam Santaniello, et al.
Neurology|August 29, 2022
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple SclerosisChristian Cordano, Bardia Nourbakhsh, Hao H Yiu, et al.
Brain : a Journal of Neurology|August 7, 2016
Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasiaMaria Luisa Mandelli, Eduard Vilaplana, Jesse A Brown, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
JAMA Neurology|June 1, 2016
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple SclerosisNoriko Isobe, Anisha Keshavan, Pierre-Antoine Gourraud, et al.
Neurology|December 23, 2024
Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple SclerosisHannah E Silverman, Alan Bostrom, Alyssa N Nylander, et al.
Multiple Sclerosis and Related Disorders|April 9, 2022
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trialRiley Bove, Annika Anderson, William Rowles, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Nature Communications|May 20, 2024
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Brain : a Journal of Neurology|December 16, 2017
Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injuryBruce A C Cree, Jianqin Niu, Kimberly K Hoi, et al.
Brain : a Journal of Neurology|March 7, 2022
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in EuropeansHengameh Shams, Xiaorong Shao, Adam Santaniello, et al.
Neurology|August 29, 2022
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple SclerosisChristian Cordano, Bardia Nourbakhsh, Hao H Yiu, et al.
Brain : a Journal of Neurology|August 7, 2016
Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasiaMaria Luisa Mandelli, Eduard Vilaplana, Jesse A Brown, et al.
Pageof 15